Cargando…
CCDC114, DNAI2 and TOP2A involves in the effects of tibolone treatment on postmenopausal endometrium
BACKGROUND: This study aimed to explore the molecular mechanisms of tibolone treatment in postmenopausal women. METHODS: The gene set enrichment profile, GSE12446, which includes 9 human endometrial samples from postmenopausal women treated with tibolone (tibolone group) and 9 control samples (contr...
Autores principales: | Lv, Yanhua, Liu, Yanqing, Wang, Yueqiang, Kong, Fanrong, Pang, Qiuxiang, Hu, Guirong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8194000/ https://www.ncbi.nlm.nih.gov/pubmed/34116668 http://dx.doi.org/10.1186/s12905-020-01156-6 |
Ejemplares similares
-
Comparative safety and efficacy of tibolone and escitalopram in postmenopausal women
por: Raj, Rajnish, et al.
Publicado: (2021) -
Unintended target effect of anti-BCL-2 DNAi
por: Ebrahim, Abdul Shukkur, et al.
Publicado: (2017) -
Comparison of the Efficacy of Tibolone and Transdermal Estrogen in Treating Menopausal Symptoms in Postmenopausal Women
por: Kim, Hyun Kyun, et al.
Publicado: (2019) -
Effects of hormone replacement therapy and tıbolone on skın thıckness and bone ın postmenopausal women
por: Demir, Berfu, et al.
Publicado: (2006) -
Effect of Tibolone on Bone Mineral Density in Postmenopausal Women: Systematic Review and Meta-Analysis
por: Castrejón-Delgado, Lizett, et al.
Publicado: (2021)